Derek Jantz - May 14, 2021 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
Chief Scientific Officer, Director
Signature
/s/ Dario Scimeca, Attorney-in-Fact for Derek Jantz
Stock symbol
DTIL
Transactions as of
May 14, 2021
Transactions value $
-$87,841
Form type
4
Date filed
5/18/2021, 04:25 PM
Previous filing
May 14, 2021
Next filing
May 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DTIL Common Stock Options Exercise $861 +21.5K +0.53% $0.04* 4.06M May 14, 2021 Direct
transaction DTIL Common Stock Sale -$88.7K -9.67K -0.24% $9.17 4.05M May 14, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DTIL Employee Stock Option (Right to Buy) Options Exercise $0 -21.5K -100% $0.00* 0 May 14, 2021 Common Stock 21.5K $0.04 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.
F2 The option is fully vested and exercisable.